Mesothelioma in australia: A review
© 2017 AMPCo Pty Ltd. Produced with Elsevier B.V. All rights reserved. · The incidence of malignant mesothelioma in Australia is among the highest in the world as a result of widespread use of asbestos by industry and in construction throughout the 20th century. · The risk of developing malignant me...
| Main Authors: | , , |
|---|---|
| Format: | Journal Article |
| Published: |
Australasian Medical Publishing
2017
|
| Online Access: | http://hdl.handle.net/20.500.11937/62373 |
| _version_ | 1848760838174801920 |
|---|---|
| author | Musk, A. de Klerk, N. Brims, Fraser |
| author_facet | Musk, A. de Klerk, N. Brims, Fraser |
| author_sort | Musk, A. |
| building | Curtin Institutional Repository |
| collection | Online Access |
| description | © 2017 AMPCo Pty Ltd. Produced with Elsevier B.V. All rights reserved. · The incidence of malignant mesothelioma in Australia is among the highest in the world as a result of widespread use of asbestos by industry and in construction throughout the 20th century. · The risk of developing malignant mesothelioma after asbestos exposure is dose-related; a transient, low dose exposure confers a correspondingly very low risk of disease. · Malignant mesothelioma is a heterogeneous disease, partly explaining the limited role of biomarkers in screening and diagnosis. · The prognosis remains poor, and early advice on medico-legal compensation and a collaborative team approach to managing malignant mesothelioma are both essential. · Chemotherapy can have a modest treatment effect in some people. New therapies, such as immunotherapy, do not yet have a defined role in the treatment of malignant mesothelioma. · As treatment options for malignant mesothelioma are limited and no cure is available, there is no established role for early detection or screening of at risk populations. · A multidisciplinary approach to caring for patients with malignant mesothelioma and their carers is vital. |
| first_indexed | 2025-11-14T10:22:08Z |
| format | Journal Article |
| id | curtin-20.500.11937-62373 |
| institution | Curtin University Malaysia |
| institution_category | Local University |
| last_indexed | 2025-11-14T10:22:08Z |
| publishDate | 2017 |
| publisher | Australasian Medical Publishing |
| recordtype | eprints |
| repository_type | Digital Repository |
| spelling | curtin-20.500.11937-623732018-02-01T05:57:51Z Mesothelioma in australia: A review Musk, A. de Klerk, N. Brims, Fraser © 2017 AMPCo Pty Ltd. Produced with Elsevier B.V. All rights reserved. · The incidence of malignant mesothelioma in Australia is among the highest in the world as a result of widespread use of asbestos by industry and in construction throughout the 20th century. · The risk of developing malignant mesothelioma after asbestos exposure is dose-related; a transient, low dose exposure confers a correspondingly very low risk of disease. · Malignant mesothelioma is a heterogeneous disease, partly explaining the limited role of biomarkers in screening and diagnosis. · The prognosis remains poor, and early advice on medico-legal compensation and a collaborative team approach to managing malignant mesothelioma are both essential. · Chemotherapy can have a modest treatment effect in some people. New therapies, such as immunotherapy, do not yet have a defined role in the treatment of malignant mesothelioma. · As treatment options for malignant mesothelioma are limited and no cure is available, there is no established role for early detection or screening of at risk populations. · A multidisciplinary approach to caring for patients with malignant mesothelioma and their carers is vital. 2017 Journal Article http://hdl.handle.net/20.500.11937/62373 10.5694/mja17.00397 Australasian Medical Publishing restricted |
| spellingShingle | Musk, A. de Klerk, N. Brims, Fraser Mesothelioma in australia: A review |
| title | Mesothelioma in australia: A review |
| title_full | Mesothelioma in australia: A review |
| title_fullStr | Mesothelioma in australia: A review |
| title_full_unstemmed | Mesothelioma in australia: A review |
| title_short | Mesothelioma in australia: A review |
| title_sort | mesothelioma in australia: a review |
| url | http://hdl.handle.net/20.500.11937/62373 |